期刊文献+

冠心病患者血清半乳糖凝集素-3的检测及其临床意义 被引量:5

Detection of Serum Galectin-3 in Patients with Coronary Heart Disease and Its Clinical Signifi-cance
下载PDF
导出
摘要 【目的】观察冠心病及其不同分型患者血清中半乳糖凝集素-3(Gal-3)的水平,分析其与高敏 C反应蛋白(hs-CRP)、单核细胞趋化因子-1(MCP-1)的相关性,探讨 Gal-3在冠心病患者中的临床价值。【方法】收集经冠状动脉造影确诊的冠心病患者97例作为冠心病组,其中稳定性心绞痛组31例,不稳定心绞痛组35例,急性心肌梗死组31例,并收集冠脉造影正常的非冠心病患者30例作为对照组。采集入选病例一般临床资料,检测其血清 Gal-3、MCP-1及血浆 hs-CRP浓度。【结果】冠心病组血清 Gal-3水平明显高于对照组(P<0.05),不稳定心绞痛组和急性心肌梗死组血清 Gal-3水平显著高于稳定性心绞痛组(P<0.05),而急性心肌梗死组血清 Gal-3水平高于不稳定心绞痛组,但差异不具统计学意义(P >0.05);冠心病患者血清 Gal-3水平与 hs-CRP、MCP-1水平显著正相关(P <0.05)。【结论】冠心病患者血清 Gal-3水平明显增高,血清Gal-3有望成为急性冠脉综合征新的生化标志物,具有重要的临床意义。联合检测 Gal-3、hs-CRP及 MCP-1对冠心病的早期诊断、危险分层及预后具有重要临床意义。 [Objective]To observe serum level of galectin-3(Gal-3)in patients with different types of coro-nary heart disease and analyze its correlation with high-sensitivity C-reactive protein(hs-CRP)and monocyte chemokine protein-1(MCP-1),and to explore clinical value of Gal-3 in patients with coronary heart disease.[Methods]Totally 97 patients with coronary heart disease confirmed by coronary angiography were collected as coronary heart disease groups including stable angina pectoris group(group SA,n=31),unstable angina pec-toris group(group UA,n=35)and acute myocardial infarction(group AMI,n=31).Other 30 non-coronary heart disease patients with normal coronary angiography were collected as control group.General clinical data of all subjects were collected.Serum levels of Gal-3,MCP-1 and plasma hs-CRP were assayed.[Results]Ser-um Gal-3 level in coronary heart disease group was obviously higher that in control group(P0.05). Serum Gal-3 level in patients with coronary heart disease was positively correlated with hs-CRP and MCP-1 significantly(P〈0.05).[Conclusion]Serum Gal-3 level in patients with coronary heart disease is increased obviously,and may be a new biomarker for acute coronary syndrome,and has important clinical significance. Combined detection of Gal-3,hs-CRP and MCP-1 has important clinical significance in the early diagnosis,risk stratification and prognosis of coronary heart disease.
出处 《医学临床研究》 CAS 2014年第5期852-855,共4页 Journal of Clinical Research
关键词 冠心病 血液 半乳糖凝集素3 诊断 Coronary Disease/BL Galectin 3/DI
  • 相关文献

参考文献12

  • 1Li J J, Feng CH. Atherosclerosis is a more rational term for the pathological entity currently knowed as atherosclerosis [J]. Med Hypotheses, 2004,63 (1) : 100-102.
  • 2Von Hundelshausen P, Weber C. Chronic inflammation and atherosclerosis[J]. Dtsch Med Wochenschr , 2013,138 (37) : 1839-1844.
  • 3Dumic J,Dabelic s,Flogel M. Galectin-3.. An open-ended story [J]. Biochlm Biophys Acta , 2006,1760(4) ..778-789.
  • 4Lee YJ. Spatial and temporal expression, and statin respon- siveness of galectin-1 and galectin-3 in routine atherosclerosis [J]. Korean Circ J, 2013,43(4) :223-230.
  • 5Mackinnon AC,Liu X, Hadoke PW, et al. Inhibition of galec- tin-3 reduces atherosclerosis in apolipoprotein E-deficient mice [J]. Gtycobiology, 2013,23(6) : 654-663.
  • 6Tsai TH,Sung PH,Chang LT, et al . Value and level of ga-lectin-3 in acute myocardial infarction patients undergoing pri- mary percutaneous coronary intervention[J]. J Atheroscler Thromb , 2012,19 (12) : 1073-1082.
  • 7MacKinnon AC, Farnworth SL, Hodkinson PS, et al . Regula- tion of alternative macrophage activation by galetin-3[J]. J Immunol, 2008,180(4) :2650-2658.
  • 8Price CL,Knight SC. Advanced glycation: a novel outlook on atherosclerosis [J]. Curr Pharm Design, 2007,36 (13) .. 3681- 3687.
  • 9Papaspyridonos M, McNeilI E,de Bono JP, et al . Galectin-3 is an amplifier of inflammation in atherosclerotic plaque pro- gression through macrophage activation and monocyte che- moattraction[J]. Arterioscler Thromb Vasc Biol, 2008, 28 (3) :433-440.
  • 10Naehtigal M, Ghaffar A, Mayer EP. Galectin-3 gene inaetiva tion reduces atheroselerotic lesions and adventitial inflamma tion in ApoE-defieient miee[J]. Am J Pathol, 2008,172(1) 247-255.

同被引文献38

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部